WASHINGTON, D.C. (Thursday, March 25, 2010) - The Biotechnology Industry Organization (BIO) today announces that Wednesday, May 5th has been named International Day, and will include a special programming track on Global Biotechnology Issues. International Case Studies will be presented throughout the week on topics such as breakthroughs in molecular diagnostics, biomarkers, dementia and Alzheimer's, and translational R&D.


 "We are pleased to provide a full day of programming dedicated to our international attendees and the life sciences innovations we see happening around the world," said Robbi Lycett, vice president of Conventions and Conferences at BIO.  "Our International Case Studies track will feature experts from 15 countries who will share their insights and answer questions about country specific issues."


Presentations and breakout sessions at the 2010 BIO International Convention will focus on research and development, partnership opportunities, and new business models required to meet global health challenges. 


Also on Wednesday, editorial staff from Scientific American, along with other industry leaders, will present Worldview 2010 and discuss the state of biotech hubs and innovation around the globe and  present results of the study highlighting key international developments.  The session will be moderated by Fareed Zakaria, author, journalist and host of CNN's Fareed Zakaria GPS.  Scientific American's annual global biotech edition, Worldview 2010, enumerates the factors promoting and impeding biotech innovation on a country by country basis.  An International Reception will follow.


Countries selected to present International Case Studies include:


§     Brazil: BR BIOTEC BRASIL: A Brazilian Biotech Overview

§     France: Therapeutic Proteins, including Monoclonal Antibodies: New Challenges

§     Germany: Beyond Classical Diagnostics: Breakthroughs in Molecular Diagnostics and Biomarkers from Germany

§     India: Role of Indian Biotech Industry in Promoting Global health

§     Israel: Innovative Structures Promoting Commercialization of Israeli Life Sciences

§     Japan: From Regional to Global?Open Innovation Giving Boost to Japanese Bio SMEs

§     Mexico: Emerging Trends and Issues for Commercial Biotechnology Expansion in Mexico

§     Netherlands: Competitive Cooperation: How Partnerships Drive Life Sciences in The Netherlands

§     Poland: The Global Innovation Network

§     Russia: From Bioeducation to Bionanotechnology

§     Spain: Plaques, Tangles and Beyond: Therapeutic and Diagnostics Avenues for Neurodegenerative Diseases in Spain

§     Switzerland: Innovative Platforms for Binding Protein Therapeutics

§     Taiwan:  Mega Fund for Taiwan's Biotech Development

§     Thailand: A Thai-U.S. Joint Venture: Antibody Array?The Future Screening Method for Food Safety

§     United Kingdom: Lost in Translation: Translational R&D as the Road Map to Market


The BIO Exhibition will feature countries from across the globe.  Currently, Australia, Belgium, Canada, France, Germany, the Netherlands, Spain, Sweden, Switzerland, and the United Kingdom round out the top ten countries in terms of expected attendance for 2010.  Public officials from more than 16 countries are expected to attend.  There will be 36 official delegations in attendance to promote the benefits of establishing operations within their countries. China, for example, plans a major presence at the Convention each year.  


"China has an emerging bio-med and drug market, a strong policy environment, investment support for innovation by our government, and huge developmental potential due to comparative advantages in cost and efficiency," stated a representative from the China Pavilion.  "We will use our time at the 2010 BIO International Convention to meet with potential partners and hopefully bring new business back to China."


The 2010 BIO International Convention is expected to draw between 15,000 and 17,000 industry leaders from 48 states and 60 countries.  This year, the Convention program will feature more than 125 sessions in 17 tracks.  New tracks for 2010 include Delivery and Manufacturing of Biologics & Drugs, Global Drug Development and Marketing, Innovations in Vaccines, and Marketplace Watch.


In addition, this year's BIO Exhibition will cover an estimated 200,000 net sq. ft. and host more than 1,800 exhibitors. Product Focus Zones within the BIO Exhibition will include BioProcess, Business Services, Clinical Trials, Contracts, Discovery and the BioPark.


Advance media registration for the 2010 BIO International Convention is now open and will be available online through April 23, 2010.  To register in advance, please visit .



The BIO International Convention helps to support BIO programs and initiatives.  BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.  For more information on the global event for biotechnology, including program and housing information, please visit  

Upcoming BIO Events

BIO Intellectual Property Counsels Spring Conference and Committee Meeting

April 19-21, 2010

New Orleans, LA 

Partnering for Global Health

May 3, 2010

Chicago, IL

McCormick Place Convention Center

BIO International Convention

May 3-6, 2010

Chicago, IL

McCormick Place Convention Center

2010 BIO Human Resources Conference

May 4-7, 2010

Chicago, IL 

World Congress on Industrial Biotechnology and Bioprocessing

June 27-30, 2010

Washington, DC

BIO India

September 21 - 22, 2010

Hyderabad, India


BIO's Livestock Biotechnology Summit

September 28-30, 2010,

Sioux Falls, SD

 About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.